Skip to main content
. 2015 Dec 15;7(4):4806–4816. doi: 10.18632/oncotarget.6624

Table 2. Clinical characteristics of patients, according to the classification in the molecular subtypes and cellular origin [13].

GCB ABC P
Gender
Female 19 (48.7%) 17 (54.8%) 0.6108
Male 20 (51.3%) 14 (45.2%)
Age
<60 years 17 (43.6%) 15 (48.4%) 0.6890
≥ 60 years 22 (56.4%) 16 (51.6%)
Ann Arbor Staging
I/II 17 (43.6%) 12 (38.7%) 0.6805
III/IV 22 (56.4%) 19 (61.3%)
IPI
0-1 (low) 11 (28.2%) 5 (16.1%) 0.3994
2-3 (intermediate) 18 (46.1%) 19 (61.3%)
4-5 (high) 9 (23.1%) 7 (22.6%)
Not assessed 1 (2.6%) 0